OVOCA BIO PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.006 EUR | 0.00% |
|
0.00% | -40.00% |
| 2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 532K | - | - | - | - | - | |
| 115B | ||||||
| 106B | ||||||
| 21.96B | - | |||||
| 21.84B | - | |||||
| 19.21B |
- Stock Market
- Equities
- OVXA Stock
- Charts Ovoca Bio plc
- Sector Chart